Theranostics Services

Theranostics are a rapidly growing field. The idea behind this includes a combination of therapeutics and diagnostics in one molecule. Peptides are an ideal support for delivery of both, radioactive markers and therapies to a tumor tissue. Biosynth has a proven track record in the field of radiopharmaceuticals and synthesis of radiolabeled precursors suitable for a wide range of applications. Next to custom synthesis, Biosynth also has a platform of Peptide discovery which allows the development of novo peptides. These services utilize our unique CLIPS™ phage display platform to discover highly constrained de novo peptides with enhanced affinities, selectivities and proteolytic stabilities.

To learn more please click on the brochure below: